NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment ...

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

NDAQ:REGN) REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES ...

Aaron Wealth Advisors LLC cut its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities and ...

Kimball Electronics, Inc. today announced that it will report second quarter fiscal year 2025 financial results on Tuesday, February 4, 2025, after the closing of the market. The company will host a ...

Pomerantz LLP is investigating claims on behalf of investors of Quantum Computing, Inc. ("Quantum Computing" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

H.C. Wainwright reaffirmed its Buy rating on shares of Legend Biotech Corp . (NASDAQ:LEGN) shares, maintaining a $73.00 price ...

Clarius Group LLC trimmed its holdings in Monster Beverage Co. (NASDAQ:MNST – Free Report) by 16.5% during the 4th quarter, ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,185.00.

NDAQ:REGN) Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...

Levi & Korsinsky, LLP notifies investors in Micron Technology, Inc. ("Micron" or the "Company") of a class action securities ...